Teneligliptin hydrobromide
Catalog No. A15258
Teneligliptin hydrobromide是一种新颖,有效且持久的二肽基肽酶-4抑制剂。在体外竞争性抑制人血浆,大鼠血浆和人重组DPP-4,IC50值约为1 nM。
Catalog Num | A15258 |
---|---|
M. Wt | 1257.72 |
Formula | C44H65Br5N12O2S2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 906093-29-6 |
Synonyms | |
SMILES | CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.Br.Br.Br.Br.Br |
Teneligliptin hydrobromide是一种新颖,有效且持久的二肽基肽酶-4抑制剂。在体外竞争性抑制人血浆,大鼠血浆和人重组DPP-4,IC50值约为1 nM。
Targets
Dipeptidyl peptidase-4 | DPP-9 | DPP-8 | FAP | |
1.75 nM | 150 nM | 189 nM | >10 μM |
In vitro | DMSO | 85 mg/mL (135.16 mM) | |
Water | 85 mg/mL (135.16 mM) | ||
Ethanol | 14 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 7.95 mL | 39.75 mL | 79.51 mL |
0.5 mM | 1.59 mL | 7.95 mL | 15.9 mL |
1 mM | 0.8 mL | 3.98 mL | 7.95 mL |
5 mM | 0.16 mL | 0.8 mL | 1.59 mL |
*The above data is based on the productmolecular weight 1257.72. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.